With its diverse range of functions, SIRT5 presents a potential target for developing agonists or inhibitors that can serve as effective therapeutic agents for an array of illnesses, including cancer, cardiovascular disease, and neurodegeneration. This evidence concerns the gene SIRT5 and cancer.